All In MedTech

Device Trial Radar · NCT02372877

Evaluation of the AMICUS RBCx System in Sickle Cell Patients

Evaluation of the AMICUS Red Blood Cell Exchange (RBCx) System in Sickle Cell Patients

Last checked: Nov 19, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

83

Actual

Start

May 2015

Primary completion

Dec 7, 2017

Study completion Jan 19, 2018

Sponsor

Lead sponsor
Fenwal, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Versiti Blood Health; Children's Hospital of Philadelphia; Barbara Ann Karmanos Cancer Institute; University of Texas; Washington University School of Medicine; Phoenix Children's Hospital
First posted
Feb 26, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the performance of the AMICUS Red Blood Cell Exchange (RBCx) System (Exchange and Depletion/Exchange procedures) in patients with sickle cell disease.

Conditions

  • Sickle Cell Anemia

Interventions

  • Amicus Red Cell Exchange in SCD patientsDevice

    Each patient will be treated with one RBCx procedure using the AMICUS RBCx System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Actual Fraction of Original Red Blood Cells Remaining to the Target Fraction of Cells Remaining (FCR).Time frame: Actual FCR will be assessed by taking a pre-procedure sample from the patient on the day of the procedure and a post-procedure sample approximately 10-15 min after procedure completion.

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Phoenix Children's Hospital

    Phoenix, Arizona

  • Barbara Ann Karmanos Cancer Institute

    Detroit, Michigan

  • Washington University

    St Louis, Missouri

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.